Tapewire

Nasdaq · USD

HRTX

HERON THERAPEUTICS, INC. /DE/

Export transactions ↓
Tapewire entity
7133
SEC CIK
0000818033
Parsed reports
288

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 13, 2023 Filed Apr 17, 2023 21:28 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 1,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-024500 · doc4.xml · derivative · entry 4

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 1,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:28 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Tax withholdingCommon Stock 2,012 $2.88 $5,794.56
Disclosure

SEC source: 0001209191-23-024500 · doc4.xml · nonDerivative · entry 3

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,952

F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:28 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Exercise / conversionCommon Stock 4,564 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024500 · doc4.xml · nonDerivative · entry 2

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:28 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Exercise / conversionCommon Stock 1,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024500 · doc4.xml · nonDerivative · entry 1

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:27 UTC
POYHONEN JOHNPresident & CCO
Exercise / conversionRestricted Stock Units · Derivative 4,564 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-024499 · doc4.xml · derivative · entry 5

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,936

Underlying: Common Stock · 4,564 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:27 UTC
POYHONEN JOHNPresident & CCO
Exercise / conversionRestricted Stock Units · Derivative 1,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-024499 · doc4.xml · derivative · entry 4

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 1,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:27 UTC
POYHONEN JOHNPresident & CCO
Tax withholdingCommon Stock 2,012 $2.88 $5,794.56
Disclosure

SEC source: 0001209191-23-024499 · doc4.xml · nonDerivative · entry 3

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,648

F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:27 UTC
POYHONEN JOHNPresident & CCO
Exercise / conversionCommon Stock 4,564 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024499 · doc4.xml · nonDerivative · entry 2

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:27 UTC
POYHONEN JOHNPresident & CCO
Exercise / conversionCommon Stock 1,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024499 · doc4.xml · nonDerivative · entry 1

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,096

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:27 UTC
Peraza LisaVP, Chief Accounting Officer
Exercise / conversionRestricted Stock Units · Derivative 1,932 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-024498 · doc4.xml · derivative · entry 5

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,829

Underlying: Common Stock · 1,932 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:27 UTC
Peraza LisaVP, Chief Accounting Officer
Exercise / conversionRestricted Stock Units · Derivative 552 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-024498 · doc4.xml · derivative · entry 4

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,312

Underlying: Common Stock · 552 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:27 UTC
Peraza LisaVP, Chief Accounting Officer
Tax withholdingCommon Stock 860 $2.88 $2,476.80
Disclosure

SEC source: 0001209191-23-024498 · doc4.xml · nonDerivative · entry 3

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,685

F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:27 UTC
Peraza LisaVP, Chief Accounting Officer
Exercise / conversionCommon Stock 1,932 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024498 · doc4.xml · nonDerivative · entry 2

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,545

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:27 UTC
Peraza LisaVP, Chief Accounting Officer
Exercise / conversionCommon Stock 552 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024498 · doc4.xml · nonDerivative · entry 1

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,613

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:26 UTC
MANHARD KIMBERLYEVP, Drug Development
Exercise / conversionRestricted Stock Units · Derivative 4,564 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-024497 · doc4.xml · derivative · entry 5

MANHARD KIMBERLY · CIK 0001202094 · EVP, Drug Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,936

Underlying: Common Stock · 4,564 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:26 UTC
MANHARD KIMBERLYEVP, Drug Development
Exercise / conversionRestricted Stock Units · Derivative 1,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-024497 · doc4.xml · derivative · entry 4

MANHARD KIMBERLY · CIK 0001202094 · EVP, Drug Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 1,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:26 UTC
MANHARD KIMBERLYEVP, Drug Development
Tax withholdingCommon Stock 1,417 $2.88 $4,080.96
Disclosure

SEC source: 0001209191-23-024497 · doc4.xml · nonDerivative · entry 3

MANHARD KIMBERLY · CIK 0001202094 · EVP, Drug Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,330

F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:26 UTC
MANHARD KIMBERLYEVP, Drug Development
Exercise / conversionCommon Stock 4,564 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024497 · doc4.xml · nonDerivative · entry 2

MANHARD KIMBERLY · CIK 0001202094 · EVP, Drug Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,747

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
April 13, 2023 Filed Apr 17, 2023 21:26 UTC
MANHARD KIMBERLYEVP, Drug Development
Exercise / conversionCommon Stock 1,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024497 · doc4.xml · nonDerivative · entry 1

MANHARD KIMBERLY · CIK 0001202094 · EVP, Drug Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,183

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 21:10 UTC
Collard Craig ADirector · Chief Executive Officer
GrantEmployee Performance Stock Option (Right to Buy) · Derivative 4,250,000 $0.00 Strike: $1.78 $0.00
Disclosure

SEC source: 0001209191-23-023385 · doc4.xml · derivative · entry 3

Collard Craig A · CIK 0001363558 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,250,000

Underlying: Common Stock · 4,250,000 shares

Expires 2033-04-03

F3 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to escalating portions of the option grant upon the Issuer's stock price reaching certain pre-established levels ranging from $4.50 to $9.00 per share, subject to the Reporting Person's continued service to the Issuer through the vesting date.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 21:10 UTC
Collard Craig ADirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 250,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-023385 · doc4.xml · derivative · entry 2

Collard Craig A · CIK 0001363558 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires not disclosed

F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date.

F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 21:10 UTC
Collard Craig ADirector · Chief Executive Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 3,000,000 $0.00 Strike: $1.78 $0.00
Disclosure

SEC source: 0001209191-23-023385 · doc4.xml · derivative · entry 1

Collard Craig A · CIK 0001363558 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000,000

Underlying: Common Stock · 3,000,000 shares

Expires 2033-04-03

F1 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 750,000 shares on the first anniversary of the date of grant, followed by 2,250,000 shares vesting ratably each month over the subsequent three years, such that 3,000,000 options will be fully vested on the four-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date.

Read SEC document
February 22, 2023 Filed Feb 25, 2023 00:20 UTC
Morgan AdamDirector · See Notes 2 & 3
GrantStock Option (Right to Buy) · Derivative 227,272 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001209191-23-012924 · doc4.xml · derivative · entry 3

Morgan Adam · CIK 0001964335 · Director · See Notes 2 & 3

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,272

Underlying: Common Stock · 227,272 shares

Expires 2033-02-22

F4 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (02/22/2023).

Read SEC document
February 22, 2023 Filed Feb 25, 2023 00:20 UTC
Morgan AdamDirector · See Notes 2 & 3
GrantCommon Stock 37,879 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-012924 · doc4.xml · nonDerivative · entry 1

Morgan Adam · CIK 0001964335 · Director · See Notes 2 & 3

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,879

F1 · shares: The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning three months after the date of grant (02/22/2023).

Read SEC document
January 18, 2023 Filed Jan 20, 2023 22:10 UTC
Szekeres David LeslieEVP, Chief Operating Officer
GrantPerformance Stock Units · Derivative 49,788 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-004304 · doc4.xml · derivative · entry 1

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,788

Underlying: Common Stock · 49,788 shares

Expires not disclosed

F1 · derivative.exercise_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested.

F1 · derivative.expiration_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested.

Read SEC document
January 18, 2023 Filed Jan 20, 2023 22:10 UTC
Quart Barry DDirector · Chief Executive Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 850,000 $0.00 Strike: $3.13 $0.00
Disclosure

SEC source: 0001209191-23-004303 · doc4.xml · derivative · entry 1

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 850,000

Underlying: Common Stock · 850,000 shares

Expires 2033-01-18

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant.

Read SEC document
January 18, 2023 Filed Jan 20, 2023 22:09 UTC
POYHONEN JOHNPresident & CCO
GrantPerformance Stock Units · Derivative 66,385 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-004302 · doc4.xml · derivative · entry 1

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,385

Underlying: Common Stock · 66,385 shares

Expires not disclosed

F1 · derivative.exercise_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested.

F1 · derivative.expiration_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested.

Read SEC document
January 18, 2023 Filed Jan 20, 2023 22:09 UTC
Peraza LisaVP, Chief Accounting Officer
GrantPerformance Stock Units · Derivative 42,631 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-004301 · doc4.xml · derivative · entry 1

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,631

Underlying: Common Stock · 42,631 shares

Expires not disclosed

F1 · derivative.exercise_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested.

F1 · derivative.expiration_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested.

Read SEC document
January 18, 2023 Filed Jan 20, 2023 22:08 UTC
MANHARD KIMBERLYDirector · EVP, Drug Development
GrantPerformance Stock Units · Derivative 149,365 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-004299 · doc4.xml · derivative · entry 1

MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,365

Underlying: Common Stock · 149,365 shares

Expires not disclosed

F1 · derivative.exercise_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested.

F1 · derivative.expiration_date: On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:37 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 4,564 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-003564 · doc4.xml · derivative · entry 6

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

Underlying: Common Stock · 4,564 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:37 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 1,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-003564 · doc4.xml · derivative · entry 5

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,750

Underlying: Common Stock · 1,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F4 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:37 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Tax withholdingCommon Stock 2,012 $3.17 $6,378.04
Disclosure

SEC source: 0001209191-23-003564 · doc4.xml · nonDerivative · entry 4

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,150

F3 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:37 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Exercise / conversionCommon Stock 4,564 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-003564 · doc4.xml · nonDerivative · entry 3

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,162

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:37 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Exercise / conversionCommon Stock 1,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-003564 · doc4.xml · nonDerivative · entry 2

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,598

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:36 UTC
Quart Barry DDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 16,122 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-003563 · doc4.xml · derivative · entry 6

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,807

Underlying: Common Stock · 16,122 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:36 UTC
Quart Barry DDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 3,645 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-003563 · doc4.xml · derivative · entry 5

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,521

Underlying: Common Stock · 3,645 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F4 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:36 UTC
Quart Barry DDirector · Chief Executive Officer
Tax withholdingCommon Stock 5,219 $3.17 $16,544.23
Disclosure

SEC source: 0001209191-23-003563 · doc4.xml · nonDerivative · entry 4

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,989

F3 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:36 UTC
Quart Barry DDirector · Chief Executive Officer
Exercise / conversionCommon Stock 16,122 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-003563 · doc4.xml · nonDerivative · entry 3

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,208

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:36 UTC
Quart Barry DDirector · Chief Executive Officer
Exercise / conversionCommon Stock 3,645 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-003563 · doc4.xml · nonDerivative · entry 2

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 167,086

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:36 UTC
POYHONEN JOHNPresident & CCO
Exercise / conversionRestricted Stock Units · Derivative 4,564 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-003562 · doc4.xml · derivative · entry 5

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

Underlying: Common Stock · 4,564 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:36 UTC
POYHONEN JOHNPresident & CCO
Exercise / conversionRestricted Stock Units · Derivative 1,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-003562 · doc4.xml · derivative · entry 4

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,750

Underlying: Common Stock · 1,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:36 UTC
POYHONEN JOHNPresident & CCO
Tax withholdingCommon Stock 2,012 $3.17 $6,378.04
Disclosure

SEC source: 0001209191-23-003562 · doc4.xml · nonDerivative · entry 3

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,846

F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:36 UTC
POYHONEN JOHNPresident & CCO
Exercise / conversionCommon Stock 4,564 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-003562 · doc4.xml · nonDerivative · entry 2

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,858

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:36 UTC
POYHONEN JOHNPresident & CCO
Exercise / conversionCommon Stock 1,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-003562 · doc4.xml · nonDerivative · entry 1

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,294

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:35 UTC
Peraza LisaVP, Chief Accounting Officer
Exercise / conversionRestricted Stock Units · Derivative 1,933 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-003561 · doc4.xml · derivative · entry 5

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,761

Underlying: Common Stock · 1,933 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:35 UTC
Peraza LisaVP, Chief Accounting Officer
Exercise / conversionRestricted Stock Units · Derivative 552 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-003561 · doc4.xml · derivative · entry 4

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,864

Underlying: Common Stock · 552 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:35 UTC
Peraza LisaVP, Chief Accounting Officer
Tax withholdingCommon Stock 1,013 $3.17 $3,211.21
Disclosure

SEC source: 0001209191-23-003561 · doc4.xml · nonDerivative · entry 3

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,061

F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:35 UTC
Peraza LisaVP, Chief Accounting Officer
Exercise / conversionCommon Stock 1,933 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-003561 · doc4.xml · nonDerivative · entry 2

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,074

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:35 UTC
Peraza LisaVP, Chief Accounting Officer
Exercise / conversionCommon Stock 552 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-003561 · doc4.xml · nonDerivative · entry 1

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 22:34 UTC
MANHARD KIMBERLYDirector · EVP, Drug Development
Exercise / conversionRestricted Stock Units · Derivative 4,564 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-003560 · doc4.xml · derivative · entry 6

MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

Underlying: Common Stock · 4,564 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.